Cannabis plant named &#39;GUAVA JAM&#39;

ABSTRACT

The present invention provides a new and distinct  cannabis  cultivar designated as ‘GUAVA JAM’.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority to, and the benefit of U.S. ProvisionalPatent Application Ser. No. 62/596,561, filed Dec. 8, 2017, which ishereby incorporated by reference in its entirety for all purposes.

Latin name of genus and species: Cannabis hybrid (mixed background).

Variety denomination: ‘GUAVA JAM’.

BACKGROUND OF THE INVENTION

The present invention relates to a new and distinct cannabis cultivardesignated as ‘GUAVA JAM’.

This new cultivar is the result of controlled-crosses betweenproprietary cultivars made by the inventors. The new cultivar of ‘GUAVAJAM’ was asexually reproduced via a ‘cutting’ and ‘cloning’ method bythe inventors at Salinas, Calif. Asexual clones from the original sourcehave been tested in greenhouses, nurseries, and/or fields. Theproperties of each cultivar were found to be transmissible by suchasexual reproduction. The cultivar is stable and reproduces true to typein successive generations of asexual reproduction.

TAXONOMY AND NOMENCLATURE

Cannabis, more commonly known as marijuana, is a genus of floweringplants that includes at least three species, Cannabis sativa, Cannabisindica, and Cannabis ruderalis as determined by plant phenotypes andsecondary metabolite profiles. In practice however, cannabisnomenclature is often used incorrectly or interchangeably. Cannabisliterature can be found referring to all cannabis varieties as “sativas”or all cannabinoid producing plants as “indicas”. Indeed the promiscuouscrosses of indoor cannabis breeding programs have made it difficult todistinguish varieties, with most cannabis being sold in the UnitedStates having features of both sativa and indica species.

Human cultivation history of Cannabis dates back 8000 years (Schultes, RE., 1970, Random thoughts and queries on the botany of Cannabis. Pages11-38 in: C R B Joyce, and S H Curry eds., THE BOTANY AND CHEMISTRY OFCANNABIS. J. & A. Churchill. London, England). Hemp cloth recovered inEurope dates back 6000 years (Small, E, Beckstead, H D, and Chan, A,1975, The evolution of cannabinoid phenotypes in Cannabis, ECONOMICBOTANY 29(3):219-232). The written record of the pharmacologicproperties of Cannabis goes back more than 4000 years (Ti, H. 2737 BC.NEI JING SU WEN HUANG TI, Yellow Emperor's Classic on Internal Medicine;referred to without citation in Small et al. 1975 Supra).

The taxonomy and nomenclature of the highly variable genus Cannabis(Emboden, W A, 1974, ECONOMIC BOTANY 28(3):304-310; Small, E andCronquist, A, 1976, TAXON 25(4):405-435; Small E and Cronquist, A, 1977,TAXON 26(1):110; Hillig, K W and Mahlberg, P G, 2004, American Journalof Botany 91(6):966-975), remains in question. This is in spite of thefact that its formal scientific name, ‘Cannabis sativa L.’, assigned byCarolus Linneaus (Linnaeus, C, 1753, SPECIES PLANTARUM, 2:1027, Salvius,Stockholm, Facsimile edition, 1957-1959, Ray Society, London, U.K.), isone of the oldest established names in botanical history and is stillaccepted to this day. Another species in the genus, ‘Cannabis indicaLam.’ was formally named somewhat later (de Lamarck, J B, 1785,ENCYCLOPEDIE METHODIQUE DE BOTANIQUE, 1(2):694-695), but is still veryold in botanical history. In 1785, Jean-Baptiste Lamarck published adescription of a second species of Cannabis, which he named Cannabisindica. Lamarck based his description of the newly named species onplant specimens collected in India. C. indica was described asrelatively short, conical, and densely branched, whereas C. sativa wasdescribed as tall and laxly branched (Schultes R. E. et al, 1974,Harvard University Botanical Museum Leaflets, 23:337-367). C. indicaplants were also described as having short, broad leaflets whereas thoseof C. sativa were characterized as relatively long and narrow (AndersonL. C., 1980, Harvard University Botanical Museum Leaflets, 28:61-69). C.indica plants conforming to Schultes' and Anderson's descriptions mayhave originated from the Hindu Kush mountain range. Because of the oftenharsh and variable (extremely cold winters, and warm summers) climate ofthose parts, C. indica is well-suited for cultivation in temperateclimates.

Three other species names were proposed in the 1800s to distinguishplants with presumably different characteristics (C. macrosperma Stokes,C. chinensis Delile, C. gigantean Vilmorin), none of which are acceptedtoday, although the epithet “indica” lives on as a subspecies of C.sativa (‘C. sativa ssp. indica Lam.’, Small and Cronquist 1976 Supra).

In the 20th century, two new names were added to the liturgy of proposed‘Cannabis species: C. ruderalis’ Janischevsky and a hybrid, x ‘C.intersita’ Sojak. (Small, E, Jui, P Y, and Lefkovitch, L P, 1976,SYSTEMATIC BOTANY 1(1): 67-84; Small and Cronquist 1976 Supra). Further,numerous names have been proposed for horticultural variants of‘Cannabis’ but as of 1976, “very few of these have been validlypublished as formal taxa under the International Code of BotanicalNomenclature” (Small and Cronquist 1976 Supra). Moreover, other recentwork continues to focus on higher-order evolutionary relationships ofthe genus. Cannabis has been variously ascribed as belonging to mulberryfamily (Moraceae) (Engler, H G A, Ulmaceae, Moraceae and Urticaceae,pages 59-118 in: A. Engler and K. Prantl eds., 1889, DIE NATURLICHENPFLANZENFAMILIEN 3(1). W. Engelmann, Leipzig, Germany; Judd, W S,Sanders, R W, and Donoghue, M J, 1994, HARVARD PAPERS IN BOTANY 5:1-51;Humphries, C J and Blackmore, S, A review of the classification of theMoraceae, pages 267-277 In: Crane and Blackmore 1989 id.); nettle family(Urticaceae) (Berg, C C, Systematics and phylogeny of the Urticales,pages 193-220, in: P. R. Crane and S. Blackmore eds., 1989, EVOLUTION,SYSTEMATIC, AND FOSSIL HISTORY OF THE HAMAMELIDAE, VOL. 2, HIGHERHAMAMELIDAE, Clarendon Press, Oxford, U.K.); and most recently in itsown family with hops (Humulus), Cannabaceae, or hemp family (Sytsma, KJ, et al, 2002, AMERICAN JOURNAL OF BOTANY 89(9):1531-1546). While thework of Small and Cronquist 1976 Supra, seemed to effectively confinethe genus to a single species with 2 subspecies (C. sativa s., C. s.indica), each with two varieties (C. s. s. var. sativa, C. s. s. var.spontanea; C. s. i. var. indica, C. s. i. var. Kafiristanica) largely onthe basis of chemotaxonomy and interfertility of all forms, more recentwork (Sytsma et al. 2002 Supra), proposes a two-species concept,resurrecting the binomial C. indica Lam. Since Sytsma et al. (2002)provides no key for discriminating between the species, the dichotomouskey of Small and Cronquist (1976), which accounts for all forms innature, whether wild or domesticated, is preferred to classify thecharacteristics of the plants.

BRIEF SUMMARY OF THE INVENTION

This invention relates to a new and distinctive cannabis cultivardesignated as ‘GUAVA JAM’.

The objective of the breeding program which produced novel plantsdisclosed herein was primarily to develop a cannabis cultivar with itsunique blend of various cannabinoids and/or terpenes for (a) medicinaleffects such as improving appetite and reducing nausea, vomiting and/orchronic pain, as well as neurological and cardiovascular effects, (b)psychoactive effects such as increased motivation and energetic behaviorrather than indifference, passiveness and lethargy, and (c) recreationaleffects with enhanced enjoyment such as food and aroma.

As used herein, the term “cultivar” is used interchangeably with“variety”, “strain”, and/or “clone”.

Cannabis plants produce a unique family of terpeno-phenolic compounds.Cannabinoids, terpenoids, and other compounds are secreted by glandulartrichomes that occur most abundantly on the floral calyxes and bracts offemale plants. As a drug it usually comes in the form of dried flowerbuds (marijuana), resin (hashish), or various extracts collectivelyknown as hashish oil. The cannabis plant has at least 545 distinctcompounds that span 20 chemical classes including cannabinoids,terpenes, terpenoids, amino acids, nitrogenous compounds, simplealcohols, aldehydes, ketones, esters, lactones, acids, fatty acids,steroids, non-cannabinoid phenols, pigments, flavonoids, vitamins,proteins, enzymes, glycoproteins, and hydrocarbons. Terpenes and/orcannabinoids, in particular, have shown great potential in terms ofmedicinal value.

Terpenes and/or cannabinoids have been shown to be largely responsiblefor beneficial effects of a cannabis plant. In fact, each cannabis planthas the varying concentrations of medically viable compounds dependingon different strains (genotypes) and their resulting chemotypes. Even asmall variation in terpene and/or cannabinoid concentration can causenoticeable differences in the entourage and/or synergistic effects of acannabis plant, which distinguishes one variety from another. Researchshows that it relies heavily on the physiological effects produced byterpenes and/or cannabinoids.

Over 100 different kinds of terpenes have been identified in cannabisplants although not being as well-studied as cannabinoids, they areinstrumental in giving rise to the physiological and psychoactiveeffects in cannabis.

Terpenes are a large and diverse class of organic compounds, produced bya variety of plants. They are often strong smelling and thus may havehad a protective function. Terpenes are an important component, not onlyinfluencing taste and smell of each cannabis strain but also influencingits effects on the mind and body of a subject such as humans andanimals. Terpenes are a classification of organic molecules that arefound in a wide variety of plants and animals. These molecules are knownfor their characteristic scents and flavors. The varying terpeneconcentrations found in cannabis plants directly influence the resultingtaste and smell, as well as the observed effects. Non-limiting examplesof terpenes include Hemiterpenes, Monoterpenes, Sesquiterpenes,Diterpenes, Sesterterpenes, Triterpenes, Sesquarterpenes, Tetraterpenes,Polyterpenes, and Norisoprenoids. The main terpenes found in cannabisplants include, but are not limited to, myrcene, limonene,caryophyllene, pinene, terpinene, terpinolene, camphene, terpineol,phellandrene, carene, humulene, pulegone, sabinene, geraniol, linalool,fenchol, borneol, eucalyptol, and nerolidol.

Cannabinoids are the most studied group of the main physiologicallyactive secondary metabolites in cannabis. The classical cannabinoids areconcentrated in a viscous resin produced in structures known asglandular trichomes. At least 113 different cannabinoids have beenisolated from cannabis plants. The main classes of cannabinoids fromcannabis include tetrahydrocannabinol (THC), cannabidiol (CBD),cannabigerol (CBG), and cannabinol (CBN). Cannabinoid can be at leastone of a group comprising tetrahydrocannabinol (THC), cannabidiol (CBD),cannabigerol (CBG), cannabinol (CBN) cannabichromene (CBC),cannabinodiol (CBDL), cannabicyclol (CBL), cannabivarin (CBV),tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), cannabigerovarin(CBGV), cannabichromevarin (CBCV), cannabigerol monomethyl ether (CBGM),cannabielsoin (CBE), cannabicitran (CBT), cannabinol propyl variant(CBNV), cannabitriol (CBO), tetrahydrocannabinolic acid (THCA),tetrahydrocannabivarinic acid (THCVA), cannabidiolic acid (CBDA),cannabigerolic acid (CBGA) and cannabinerolic acid.

Most cannabinoids exist in two forms, as acids and in neutral(decarboxylated) forms. The acid form is designated by an “A” at the endof its acronym (i.e. THCA). The cannabinoids in their acid forms (thoseending in “-A”) can be converted to their non-acid forms through aprocess called decarboxylation when the sample is heated. Thephytocannabinoids are synthesized in the plant as acid forms. While somedecarboxylation does occur in the plant, it increases significantlypost-harvest and the kinetics increase at high temperatures(Flores-Sanchez and Verpoorte, 2008, Plant Cell Physiol. 49(12):1767-1782). The biologically active forms for human consumption are theneutral forms. Decarboxylation is usually achieved by thorough drying ofthe plant material followed by heating it, often by combustion,vaporization, heating, or baking in an oven. Unless otherwise noted,references to cannabinoids in a plant include both the acidic anddecarboxylated versions (e.g., CBD and CBDA).

The molecules lose mass through the process of decarboxylation. In orderto find the total theoretical active cannabinoids, the acid forms shouldbe multiplied by 87.7%. For example, THCA can be converted to active THCusing the formula: THCA×0.877=THC. The maximum THC for the sample is:THC_(max)=(THCA×0.877)+THC. This method has been validated according tothe principles of the International Conference on Harmonization.Similarly, CBDA can be converted to active CBD and the yield isdetermined using the yield formula: CBDA×0.877=CBD. Also the maximumamount of CBD yielded, i.e. max CBD for the sample is:CBD_(max)=(CBDA×0.877)+CBD. Additionally, CBGA can be converted toactive CBG by multiplying 87.8% to CBGA. Thus, the maximum amount of CBGis: CBG_(max)=(CBGA×0.878)+CBG.

The biologically active chemicals found in plants, phytochemicals,affect the normal structure or function of the human body and in somecases treat disease. The mechanisms for the medicinal and psychoactiveproperties of a cannabis plant, like any medicinal herb, produce thepharmacologic effects of its phytochemicals, and the key phytochemicalsfor a medical cannabis plant are cannabinoids and terpenes.

Δ9-Tetrahydrocannabinol (THC) is a psychoactive cannabinoid responsiblefor many of the effects such as mild to moderate pain relief,relaxation, insomnia and appetite stimulation. THC has been demonstratedto have anti-depressant effects. The majority of strains range from12-21% THC with very potent and carefully prepared strains reaching evenhigher. While Δ9-Tetrahydrocannabinol (THC) is also implicated in thetreatment of disease, the psychotropic activity of THC makes itundesirable for some patients and/or indications.

Tetrahydrocannabinol, THC, is the primary psychoactive and medicinalcannabinoid and is the result of the decarboxylation oftetrahydrocannabinolic acid (THCA), its acidic precursor. THCA,(6ar,10ar)-1-hydroxy-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6h-benzochromene-2-carboxylic acid, isfound in the trichomes of the plant and converted into THC, whichactually exists in only minute quantities in the living plant, afterharvest and drying.

Cannabidiol (CBD) is one of the principal cannabinoids found in acannabis plant and is largely considered to the most medicallysignificant. CBD occurs in many strains, at low levels, <1%. In somecases, CBD can be the dominant cannabinoid, as high as 15% by weight.CBD is non-psychoactive, meaning that unlike THC, CBD does not cause anoticeable “high”. CBD has been implicated for medical properties in thetreatment of a wide variety of diseases and symptoms, including cancer,nausea, chronic pain, spasms, seizures/epilepsy, anxiety, psoriasis,Crohn's disease, rheumatoid arthritis, diabetes, schizophrenia,post-traumatic stress disorder (PTSD), alcoholism, strokes, multiplesclerosis, and cardiovascular disease. CBD also has been reported to actas a muscle relaxant, antibiotic, anti-inflammatory, and bone stimulant,as well as to improve blood circulation, cause drowsiness, and protectthe nervous system. It can provide relief for chronic pain due to musclespasticity, convulsions and inflammation, as well as effective relieffrom anxiety-related disorders. It can offer relief for patients withMultiple Sclerosis (MS), Fibromyalgia and Epilepsy. CBD has also beenshown to inhibit cancer cell growth when injected into breast and braintumors in combination with THC.

A cannabis cultivar can be used to achieve the desire of patients to betreated with CBD without the adverse side-effects (e.g., psychoactivity)of THC.

Cannabichromene (CBC) is a rare, non-psychoactive cannabinoid, usuallyfound at low levels (<1%) when present. It has been shown to haveanti-depressant effects and to improve the pain-relieving effects ofTHC. Studies have demonstrated that CBC has sedative effects such aspromoting relaxation.

Cannabidiol (CBD) and cannabichromene (CBC) are both non-psychoactiveand end products of CBG metabolism, like THC, so that they can be usedmedically.

Cannabigerol (CBG) is a non-psychoactive cannabinoid. CBG-acid is theprecursor to both THC-acid and CBD-acid in the plant usually found atlow levels (<1%) when present. It has been demonstrated to have bothpain relieving and inflammation reducing effects. CBG reducesintraocular pressure, associated with glaucoma. CBG has been shown tohave antibiotic properties and to inhibit platelet aggregation, whichslows the rate of blood clotting. While Cannabigerol (CBG), is notconsidered psychoactive, it is known to block the psychoactive effectsof THC and is considered medically active in a variety of conditions.Its precursor, cannabigerolic acid, CBGA,(E)-3-(3,7-Dimethyl-2,6-octadienyl)-2,4-dihydroxy-6-pentylbenzoic acid,is being studied medically.

Cannabinol (CBN) is an oxidative degradation product of THC. It mayresult from improper storage or curing and extensive processing, such aswhen making concentrates. It is usually formed when THC is exposed to UVlight and oxygen over time. CBN has some psychoactive properties, lessstrength than THC. CBN is thought to enhance the dizziness anddisorientation that users of cannabis may experience. It may causefeelings of grogginess, but has been shown to reduce heart rate.

High potency cannabis plants contain large quantities of specificterpenes as well as various assortments of others. For instance, acannabis plant may have a profile with either a high level of, amoderate amount of or a small amount of various terpenes depcnding onits cultivar and environmental conditions.

Various cultivars of ‘Cannabis’ species have been cultivated in aneffort to create a cultivar best suited to meet the interest ofinventors according to its own need. The particular plant disclosedherein was discovered in the area where the inventors were intentionallycross-pollinating and cultivating plants described below using standardMendelian breeding procedures well known to those of ordinary skill inthe art. This resulted in the progenies of the inventors' crosses.

The progenies resulting from any selection stage of either the crossing,selfing or backcrossing versions of the breeding regimes of the presentinvention were asexually reproduced to fix and maintain the desirableTHC content, CBs content, terpenes content, the aroma and flavor(s)typical of the desired class, and the other desirable phenotypic and/orgenotypic characteristics. The resultant selected cannabis cultivar isdesignated as ‘GUAVA JAM’ disclosed herein.

The inventors reproduced progenies asexually by cutting and cloning.This is the origin of this remarkable new cultivar. The plant has beenand continues to be asexually reproduced by cutting and cloning at theinventors' greenhouses, nurseries and/or fields in Salinas, Calif.,Oakland, Calif., and/or Washington, D.C.

The following are the most outstanding and distinguishing chemicalcharacteristics of this new cultivar when grown under normal conditionsin Salinas, Calif. Chemical analyses of the new cannabis variety and thecheck variety (or the parental varieties) disclosed herein wereperformed using standard chemical separation techniques well known tothose skilled in the art. Samples for assaying were obtained from flowertissues of the cannabis plant disclosed herein. Cannabinoid compositionof this cultivar can be determined by assaying the concentration of atleast one cannabinoid in a subset (e.g., sample) of the harvestedproduct

Table 1 includes detailed information of the cannabis plant named ‘GUAVAJAM’ for concentration ranges of terpenes and cannabinoids as tested onflowers at least three different times. The cannabis plant has beentested in a laboratory setting and/or facility to determine cannabinoidsand terpenes concentrations in the cannabis plant named ‘GUAVA JAM’according to the procedures provided in Giese et al. (Journal of AOACInternational (2015) 98(6):1503-1522).

1) The main terpenes found in ‘GUAVA JAM’ are beta-caryophyllene,limonene, alpha-humulene, linalool, myrcene, beta-pinene, fenchol, andalpha-terpineol; and

2) The estimated concentration of the total THC_(max), CBD_(max), andCBG_(max) is about 0.38-0.43%, about 8.25-10.86%, and about 0.19-0.31%,respectively, at the time of assaying metabolites from flower samples of‘GUAVA JAM’.

Terpene and cannabinoid profiles of ‘GUAVA JAM’ demonstrate that ‘GUAVAJAM’ has a phenotypically unique profile, particular insofar as to thelevel of terpenes and cannabinoids. This data is presented in a tabularform in Table 1.

TABLE 1 Ranges of Active Cannabinoids (% by weight) Max THC 0.38- MaxCBD 8.25- Max CBG 0.19- 0.43% 10.86% 0.31% Ranges of Terpenes (% byweight) thujene 0.00% gamma- 0.00% hexyl 0.01- terpinene hexanoate 0.03%alpha-pinene 0.03- linalool 0.00% octyl butyrate 0.00% 0.04% oxidecamphene 0.01% terpinolene 0.00- beta- 0.16- 0.02% caryophyllene 0.52%sabinene 0.00% fenchone 0.00% alpha- 0.17- humulene 0.38% beta-pinene0.04- linalool 0.13- cis-nerolidol 0.00% 0.06% 0.16% myrcene 0.07-fenchol 0.04- trans-nerolidol 0.03- 0.12% 0.06% 0.05% alpha- 0.00% — —caryophyllene 0.02- phellandrene oxide 0.03% carene 0.00% camphor 0.00%alpha- 0.02- bisabolol 0.03% alpha- 0.00% isoborneol 0.00% nerol 0.00%terpinene limonene 0.26- (−) borneol 0.02% geraniol 0.00% 0.41% beta-0.00% menthol 0.00% geranyl- 0.00% phellandrene acetate cineole 0.00%hexyl 0.00% methyl- 0.00% butyrate eugenol cis-ocimene 0.00% alpha-0.04- Total 1.08- terpineol 0.06% Terpenes 2.05% trans-ocimene 0.00%citronellol 0.00% — —

The cannabis plant named ‘GUAVA JAM’ has a complement of terpenes,including but not limited to, relatively high levels ofbeta-caryophyllene, limonene, alpha-humulene, linalool, myrcene,beta-pinene, fenchol, and alpha-terpineol compared to other terpenecompounds. This unique combination of differently concentrated terpenesfurther distinguishes ‘GUAVA JAM’ from other varieties in its odor, itsmedical qualities, and its effects on mood and mentation.

Physically, there are indications that its use may prevent some cancersand may prevent and/or treat diseases. Indications are that ‘GUAVA JAM’has many medical qualities that make it an important tool to maintainhealth and deal with illness.

Asexual reproduction

Asexual reproduction, also known as “cloning”, is a process well knownto those of ordinary skill in the art of cannabis production andbreeding and includes the following steps.

The cannabis cultivar disclosed herein is asexually propagated viataking cuttings of shoots and putting them in rock wool cubes. Thesecubes are presoaked with pH adjusted water and kept warm (˜80° C.). Fulltrays are covered, left under 18 hours of light and allowed to root(7-14 days). Upon root onset, the plantlets are transplanted into rigid1 gallon containers filled with a proprietary soil mix A and remain in18 hours of daylight for another 14-21 days. Once root-bound, plants aretransplanted into rigid 3 gallon containers filled with proprietary soilmix B. Immediately, the light cycle is altered to 12/12 and flowerinitiating begins. The plants remain in 12/12 lighting until harvesting.They undergo a propriety nutrient regimen and grow as undisturbed aspossible for 60-70 days depending on chemotype analysis.

All sun leaves are removed and the plant is dismantled to result inapproximately 12″ branches covered in inflorescences and trichomes. Thegoal in harvesting is to actually harvest trichome heads but not ‘buds’.Thus, great care is taken not to disturb the trichome heads and as muchof the plant remains intact as possible to promote even and slow drying.Slow drying is followed by a one to two months curing process.

Observation of the all female progenies of the original plant hasdemonstrated that this new and distinct cultivar has fulfilled theobjectives and that its distinctive characteristics are firmly fixed andhold true from generation to generation vegetatively propagated from theoriginal plant.

Under careful observation, the unique characteristics of the newcultivar have been uniform, stable and reproduced true to type insuccessive generations of asexual reproduction.

DESCRIPTION OF THE DRAWINGS

The accompanying color photographs depict characteristics of the new‘GUAVA JAM’ plants as nearly true as possible to make colorreproductions. The overall appearance of the ‘GUAVA JAM’ plants inphotographs is shown in colors that may differ slightly from the colorvalues described in the detailed botanical description.

FIG. 1 shows an overall view of the ‘GUAVA JAM’ plant from the side.

FIG. 2A shows a close view of a single leaf of the check variety BLK03plant.

FIG. 2B shows a close view of a single leaf of the new variety ‘GUAVAJAM’ plant.

FIG. 3A shows top parts (including inflorescence) of the BLK03 plantfrom the side.

FIG. 3B shows top parts (including inflorescence) of the ‘GUAVA JAM’plant from the side.

FIG. 4 shows a close view of flowers of the ‘GUAVA JAM’ plant at thelate flowering/mature stage.

FIG. 5 shows another close view of flowers of the ‘GUAVA JAM’ plant atthe late flowering/mature stage.

DETAILED BOTANICAL DESCRIPTION

‘GUAVA JAM’ has not been observed under all possible environmentalconditions, and the phenotype may vary significantly with variations inenvironment. The following observations, measurements, and comparisonsdescribe this plant as grown at Salinas, Calif., when grown in thegreenhouse, nursery or field, unless otherwise noted.

Plants for the botanical measurements in the present application areannual plants. In the following description, the color determination isin accordance with The Royal Horticultural Society Colour Chart, 1995Edition and/or newer Editions such as 2001, 2007 and 2015, except wheregeneral color terms of ordinary dictionary significance are used.

The cannabis plant disclosed herein was derived from female and maleparents that are internally designated as below.

A GNBR internal Code of the cannabis plant named ‘GUAVA JAM’ is05.09.24. The variety name of ‘GUAVA JAM’ is 03.N5.05.O3.N5.09.24.‘GUAVA JAM’ is a fertile hybrid derived from a controlled-cross betweentwo proprietary cultivars V24.S1.O3xV24.S1.N5.05 (O3.N5.05; pollenaccepter; female parent) and V24.S1.O3xV24.S1.N5.09 (O3.N5.09; pollendonor; male parent). A GNBR Breeding Code is(V24.S1.O3xV24.S1.N5.05)x(V24.S1.O3xV24.S1.N5.09).24. The initial crossbetween two parental cultivars was made in April 2015. The primaryphenotypic criteria used to select the new and distinct cannabiscultivar disclosed herein is as follows: structure score,nose/organoleptic testing, mold susceptibility/resistance, and insectsusceptibility/resistance. Also, the first asexual propagation of ‘GUAVAJAM’ occurred on Mar. 25, 2017 in Salinas, Calif.

The following traits in combination further distinguish the cannabiscultivar ‘GUAVA JAM’ from the check variety, which is BLK03. ‘GUAVA JAM’has been compared to, and can be distinguished from the check variety,‘BLK03’ as follows. All plants were raised together and evaluated when100 days old (i.e., 25 days in vegetative stage, 15 days in propagationstage, and 60 days in flowering times).

1. GENERAL

Characteristics New Variety Check Variety (BLK03) Plant life forms Anherbaceous An herbaceous plant (herb) plant (herb) Plant growth Anupright, An upright, habit tap-rooted annual tap-rooted annual plant;forming plant; forming fibrous roots fibrous roots when asexually whenasexually propagated propagated Plant origin O3.N5.05 x 03.N5.09 GLD13 XBSIA Plant Asexually Asexually propagation propagated by propagated bycuttings and cloning cuttings and cloning Propagation ease Easy ModerateHeight 0.3-1.2 m 0.5-2.5 m Width 56 cm 119.5 cm Plant vigor High MediumTime to Harvest 10 weeks 8 weeks (Seed to Harvest) Resistance toResistant to Resistant pests or diseases Powdery mildew, Botrytis, andpests Genetically- NO NO modified organism

II. LEAF/FOLIAGE

Characteristics New Variety Check Variety (BLK03) Leaf AlternateAlternate arrangement Leaf shape Palmately compound Palmately compoundLeaf structure Linear-lanceolate leaflet Linear-lanceolate leafletblades with glandular hairs blades with glandular hairs Leaf marginsDentate, coarsely serrated, Dentate, coarsely serrated, and the teethpoint away and the teeth point away from the tip from the tip Leaf hairsPresent Present Leaf length with 20.4 cm 16.6 cm petiole at maturityPetiole length at 7.7 cm 6.5 cm maturity Petiole color 53A 140C (RHSNo.) Stipule length at 0.6 cm 0.7 cm maturity Stipule shape EllipticalElliptical Stipule color 134A 149B (RHS No.) No. of leaflets 5-7 5-7Middle largest 12.1 cm 9.8 cm (longest) leaflet length Middle largest2.2 cm 2.3 cm (longest) lcaflet width Middle largest 12.1:2.2 9.8:2.3(longest) leaflet length/width ratio No. teeth of 22 25 middle leaflet(average) Leaf (upper 139B 132A side) color (RHS No.) Leaf (lower 139C134D side) color (RHS No.) Leaf glossiness Strong Strong Vein/midribObliquely continuous Obliquely continuous shape throughout leafletthroughout leaflet Vein/midrib 151D 144C color (RHS No.) Aroma Pungent,yet sweet Spicy

III. STEM

Characteristics New Variety Check Variety (BLK03) Stem shape Hollow,ribbed, large Hollow, ribbed, textured Stem diameter 2.3 cm 2.8 cm atbase Stem color 149D N144D (RHS No.)

IV. INFLORESCENCE (FEMALE/PISTILLATE FLOWERS)

Characteristics New Variety Check Variety (BLK03) Flowering Elongatedcompound spikes Elongated compound spikes (blooming) or panicles, from0.2 m- or panicles, from 0.5 m- habit 1.5 m in length 1.2 m in lengthProportion of 100% 100% female plants Inflorescence Above Even positionFlower Overlapping Overlapping-Touching arrangement Number of 420-460flowering sites 350-550 flowering sites flowers per plant Flower shapeMore or less sessile and are More or less sessile and are borne inracemes; calcarate- borne in racemes; calcarate- urceolate; a smallgreen urceolate; a small green bract enclosing the ovary bract enclosingthe ovary with two long, slender with two long, slender stigmasprojecting stigmas projecting well above the bract well above the bractFlower 0.3 cm 0.7 cm (individual pistillate) length Flower 4.7 cm 3.8 cm(compound cyme) diameter Corolla The inner envelope of floral The innerenvelope of floral leaves of a flower, of deli- leaves of a flower, ofdeli- cate texture and of some cate texture and of some color other thangreen color other than green Corolla Color N/A N/A (RHS No.) Bract shapeUrceolate Urceolate Bract color 130B N134C (RHS No.) Calyx shape Nodefined calyx No defined calyx Calyx color N/A N/A (RHS No.) Stigmashape Linear Acute Stigma length 1.9 mm 2.2 mm Stigma color 53A 159D(RHS No.) Trichome shape Capitate-stalked glandular Capitate-stalkedglandular Trichome color 157A 157A (RHS No.) Terminal bud Oblong Oblongshape Terminal bud 132C 203C color (RHS No.) Pedicel Absent AbsentStaminate N/A N/A shape Pollen Absent Absent description Seed 2.0-2.8mm; smooth 1.8-2.3 mm, smooth description and globular and globularPetal Apetalous Apetalous description Max THC About 0.38-0.43% About18.88-19.37% content Max CBD About 8.25-10.86% 0.00% content Max CBGAbout 0.19-0.31% About 0.84-0.91% content

V. OTHER CHARACTERISTICS

Characteristics New Variety Check Variety (BLK03) Time period and 6-8weeks 7-9 weeks condition of flowering/blooming Hardiness of Hardy to25° F-ambient Hardy to 25° F-ambient plant temperature temperatureBreaking action Flexible, highly resistant Strong, non-flexible tobreakage Rooting rate 99%-vigorous 70%-moderate after cutting/cloning

The following is a detailed description of the new cultivar of ‘GUAVAJAM’. The following description is for plants that are 100 days old asof the time of the measurements.

-   General description:    -   -   Plant life form and habit.—An herbaceous, upright,            tap-rooted annual plant, which forms fibrous roots when            asexually propagated.-   Classification:    -   -   Denomination.—‘GUAVA JAM’.        -   Species.—Cannabis hybrid (mixed background).-   Origin, form, and growth characteristics:    -   -   Origin.—Progeny of the controlled cross between O3.N5.05 and            O3.N5.09.        -   Propagation.—The strain is asexually propagated by cutting            and cloning.        -   Propagation ease.—Easy.-   Plant:    -   -   Height.—0.3-1.2 m.        -   Width.—56 cm.        -   Vigor.—High.        -   Pest susceptibility.—Resistant to Powdery mildew, Botrytis,            and pests.        -   Time to Harvest.—10 weeks.        -   Genetically modified organism.—No.-   Leaf/foliage:    -   -   Structure.—Linear-lanceolate leaflet blades with glandular            hairs.        -   Shape.—Palmately compound.        -   Arrangement.—Alternate.        -   Margin.—Dentate, coarsely serrated, and the teeth point away            from the tip.        -   Hair.—Present.        -   Leaf (with petiole) length at maturity.—20.4 cm.        -   Number of leaflets.—5-7.        -   Middle largest leaflet length.—12.1 cm.        -   Middle largest leaflet width.—2.2 cm.        -   Middle largest leaflet length/width ratio: 12.1:2.2.        -   Number of teeth of middle leaflet (average).—22.        -   Color.—Upper side — 139B.        -   Color.—Lower side — 139C.        -   Leaf glossiness.—Strong.        -   Veins/midrib shape.—Obliquely continuous throughout leaflet.        -   Vein/midrib color.—151D.-   Petiole:    -   -   Petiole length.—7.7 cm.        -   Petiole Color.—53A.        -   Stipule shape.—Elliptical.        -   Stipule length.—0.6 cm.        -   Stipule color.—134A.-   Stem:    -   -   Shape.—Hollow, ribbed, and large.        -   Diameter.—2.3 cm at base.        -   Color.—149D.-   Inflorescence:    -   -   Blooming/flowering habit.—Elongated compound spikes or            panicles, from 0.2-1.5 m in length.        -   Inflorescence position relative to foliage.—Above.        -   Flower arrangement.—Overlapping.        -   Number of flowers per plant.—420-460 flowering sites.-   Flowers:    -   -   Shape.—More or less sessile and are borne in racemes;            calcarate-urceolate; a small green bract enclosing the ovary            with two long, slender stigmas projecting well above the            bract.        -   Flower (individual pistillate) length.—0.3 cm.        -   Flower (compound cyme) diameter.—4.7 cm.        -   Corolla shape.—The inner envelope of floral leaves of a            flower, having delicate texture and some color other than            green.        -   Corolla color.—N/A.        -   Bract shape.—Urceolate.        -   Bract color.—130B.        -   Stigma shape.—Linear.        -   Stigma length.—1.9 mm.        -   Stigma color.—53A.        -   Trichome shape.—Capitate-stalked glandular.        -   Trichome color.—157A.        -   Cola (terminal bud).—Oblong.        -   Cola (terminal bud) color.—132C.        -   Pedicel.—Absent.        -   Pedicel color.—N/A.        -   Staminate flower.—N/A.        -   Pollen.—Absent.        -   Seed shape.—Smooth and globular.        -   Seed length.—2.0-2.8 mm.        -   Petal.—Apetalous.-   Other characteristics:    -   -   Aroma.—Pungent, yet sweet.        -   Flowering/blooming period.—6-8 weeks.        -   Hardiness.—Hardy to 25° F.-ambient temperature.        -   Breaking action.—Flexible, highly resistant to breakage.        -   Rooting rate after cutting/cloning.—99% vigorous.

1. A new and distinct cultivar of cannabis plant named ‘GUAVA JAM’substantially as shown and described herein.